Improved tumor control with antiangiogenic therapy after treatment with gemcitabine and nab‐paclitaxel in pancreatic cancer.

MLA

Zhang, Zheng, et al. “Improved Tumor Control with Antiangiogenic Therapy after Treatment with Gemcitabine and Nab‐paclitaxel in Pancreatic Cancer.” Clinical & Translational Medicine, vol. 11, no. 8, Aug. 2021, pp. 1–7. EBSCOhost, https://doi.org/10.1002/ctm2.398.

APA

Zhang, Z., Ji, S., Hu, Q., Zhuo, Q., Liu, W., Xu, W., Liu, W., Liu, M., Ye, Z., Fan, G., Xu, X., Yu, X., & Qin, Y. (2021). Improved tumor control with antiangiogenic therapy after treatment with gemcitabine and nab‐paclitaxel in pancreatic cancer. Clinical & Translational Medicine, 11(8), 1–7. https://doi.org/10.1002/ctm2.398

Chicago

Zhang, Zheng, Shunrong Ji, Qiangsheng Hu, Qifeng Zhuo, Wei Liu, Wenyan Xu, Wensheng Liu, et al. 2021. “Improved Tumor Control with Antiangiogenic Therapy after Treatment with Gemcitabine and Nab‐paclitaxel in Pancreatic Cancer.” Clinical & Translational Medicine 11 (8): 1–7. doi:10.1002/ctm2.398.